Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Entecavir injection

A technology of entecavir injection and entecavir, applied in the field of entecavir injection and its preparation, can solve the problems of malabsorption, delayed absorption of entecavir, decreased bioavailability, etc., and achieves good inhibitory effect and good stability.

Inactive Publication Date: 2010-06-02
沈阳双鼎制药有限公司
View PDF5 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the pharmaceutical preparations of entecavir marketed at home and abroad are all oral dosage forms, such as tablets and oral liquids. Eating will cause delays in the absorption of entecavir, which will lead to malabsorption and decreased bioavailability. Therefore, such oral dosage forms should be taken on an empty stomach, at least Take it two hours before or after meals to achieve better drug absorption

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Entecavir injection
  • Entecavir injection
  • Entecavir injection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Entecavir 5mg

[0044] Sodium bisulfite 0.2g

[0045] Add water for injection to 1000mL

Embodiment 2

[0047] Enteca 0.1g

[0048] Propylene glycol 2mL

[0049] Sodium bisulfite 0.2g

[0050] Add water for injection to 1000mL

Embodiment 3

[0052] Entecavir 1.0g

[0053] Propylene glycol 10mL

[0054] Sodium bisulfite 0.4g

[0055] Add water for injection to 1000mL

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an Entecavir injection comprising a small-capacity injection, a large-capacity sterilized injection and a freeze-dry sterile powder injection. The Entecavir injection is characterized by being prepared from 0.1-2.5mg of single-dosage active Entecavir and an additive which comprises a solvent for injection, 0-10% of pH regulator, 0-10% of antioxidant, 0-60% of solubilizer, 0-20% of isotonic regulator, 0.1-20% of filler and 0.1-20% of filling scaffold agent, and the percentage is the percent of the total quality of the injection in the liquid volume. The Entecavir comprises the injection and the sterile powder injection and has favorable inhibited effect on hepatitis B and good stability.

Description

technical field [0001] The invention relates to an injection of entecavir and a preparation method thereof, specifically, a sterilized solution, emulsion or suspension for injection into the body made of active form of entecavir, as well as a preparation before use Sterile powder or concentrated solution for solution or suspension. Background technique [0002] Entecavir is a guanosine analogue with the chemical name 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-hydroxymethyl-2-methylenecyclopentyl 】-1,9-dihydro-6H-purin-6-one, the molecular structure is as follows: [0003] [0004] Molecular formula C 12 h 15 N 5 o 3 , molecular weight 277.3, usually contains a crystal water, its monohydrate formula C 12 h 15 N 5 o 3 .H 2 O, molecular weight 295.3. [0005] US Patent No. 5,206,244 discloses entecavir and its use in the treatment of hepatitis B. International publications WO98 / 09964 and WO2004, 052310 respectively disclose two improved entecavir synthesis methods. US pa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/08A61K9/10A61K9/19A61K31/522A61P31/22A61P1/16
Inventor 马占芝李亚玲丁百莲
Owner 沈阳双鼎制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products